Ownership and insider activity for Align Technology, Inc. (ALGN): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry.
Price
| Price | $151.58 (closing price, November 3, 2026) |
| Market Cap | $10.8B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-27 | Blackford Quentin S. | A-Award | 1,376 | |
| 2026-08-27 | Blackford Quentin S. | |||
| 2026-05-20 | Vitalone Britt J. | A-Award | 1,836 | |
| 2026-05-20 | Vitalone Britt J. | M-Exempt | 1,443 | |
| 2026-05-20 | Vitalone Britt J. | M-Exempt | 1,443 | |
| 2026-05-20 | SIEGEL SUSAN E | M-Exempt | 1,745 | |
| 2026-05-20 | SIEGEL SUSAN E | A-Award | 1,836 | |
| 2026-05-20 | SIEGEL SUSAN E | M-Exempt | 1,745 | |
| 2026-05-20 | Saia Andrea Lynn | M-Exempt | 1,745 | |
| 2026-05-20 | Saia Andrea Lynn | A-Award | 1,836 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $389.3M | $449.5M | $636.9M | $550.4M | $960.8M | $1.10B | $942.0M | $937.4M | $1.04B | $1.08B |
| Short-term Investments | $251.0M | $272.0M | $98.5M | $318.2M | 0 | $72.0M | $57.5M | $35.3M | 0 | $15.9M |
| Receivables | $247.4M | $324.2M | $482.3M | $616.5M | $657.7M | $990.8M | $1.00B | $1.05B | $1.03B | $1.16B |
| Inventory | $27.1M | $31.7M | $55.6M | $112.1M | $139.2M | $230.2M | $338.8M | $296.9M | $254.3M | $226.3M |
| Total Current Assets | $953.0M | $1.16B | $1.30B | $1.63B | $1.85B | $2.49B | $2.42B | $2.45B | $2.49B | $2.62B |
| Property, Plant & Equipment | $175.2M | $348.8M | $521.3M | $688.0M | $817.3M | $1.20B | $1.35B | $1.41B | $1.38B | $1.24B |
| Goodwill | $61.0M | $64.6M | $64.0M | $63.9M | $444.8M | $418.5M | $407.6M | $419.5M | $442.6M | $491.8M |
| Intangible Assets | $21.0M | $24.5M | $17.9M | $11.8M | $130.1M | $109.7M | $95.7M | $82.1M | $103.5M | $93.9M |
| Total Assets | $1.40B | $1.78B | $2.05B | $2.50B | $4.83B | $5.94B | $5.95B | $6.08B | $6.21B | $6.23B |
| Accounts Payable | $28.6M | $36.8M | $64.3M | $87.2M | $142.1M | $163.9M | $127.9M | $113.1M | $108.7M | $121.5M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $31.9M |
| Total Current Liabilities | $354.3M | $497.8M | $692.1M | $971.0M | $1.33B | $1.92B | $1.93B | $2.07B | $2.04B | $1.92B |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $400.8M | $627.5M | $799.6M | $1.15B | $1.60B | $2.32B | $2.35B | $2.45B | $2.36B | $2.18B |
| Retained Earnings | $131.4M | $263.4M | $378.1M | $439.9M | $2.22B | $2.62B | $2.57B | $2.45B | $2.48B | $2.46B |
| Total Equity | $995.4M | $1.15B | $1.25B | $1.35B | $3.23B | $3.62B | $3.60B | $3.63B | $3.85B | $4.05B |
| Total Debt | 0 | 0 | 0 | $59.2M | $86.2M | $125.4M | $126.9M | $126.6M | $119.3M | $114.4M |
| Net Debt | -$640.3M | -$721.5M | -$735.4M | -$809.4M | -$874.7M | -$1.05B | -$872.7M | -$846.1M | -$924.6M | -$980.5M |
| Working Capital | $598.6M | $659.2M | $610.4M | $662.4M | $523.9M | $570.0M | $498.5M | $380.0M | $454.4M | $696.5M |
Financial Health
| Debt / Equity | 0.03 |
| Current Ratio | 1.42 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 4.77 |
Profitability
| Return on Equity | 11.76% |
| Return on Invested Capital | 10.35% |
| Return on Assets | 7.54% |
| Gross Margin | 67.58% |
| Operating Margin | 15.02% |
| Net Margin | 11.83% |
Related companies: NVST · ABT · MDT · 0Y6X.L · SYK · 0R2S.L · 0HOY.L · BSX
Explore sector: Healthcare · Medical - Devices
More sections of ALGN: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks